The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Actinium Pharmaceuticals (Inst)
Impact of geriatric vulnerability on outcomes of older patients in allogeneic hematopoietic cell transplantation.
 
Richard Jirui Lin
Employment - Pfizer (I)
Stock and Other Ownership Interests - Acadia Pharmaceuticals; Bellicum Pharmaceuticals; National HealthCare Corporation
Consulting or Advisory Role - Guidepoint Global
 
Theresa A Elko
No Relationships to Disclose
 
Sean M. Devlin
No Relationships to Disclose
 
Jessica Flynn
No Relationships to Disclose
 
Ann Alice Jakubowski
No Relationships to Disclose
 
Armin Shahrokni
No Relationships to Disclose
 
Parastoo Dahi
No Relationships to Disclose
 
Miguel-Angel Perales
Stock and Other Ownership Interests - NexImmune
Consulting or Advisory Role - Abbvie; Incyte; Medigene; Merck; MolMed; Nektar; NexImmune; Novartis; Seagen; Servier/Pfizer; Takeda
Research Funding - Incyte (Inst); Miltenyi Biotec (Inst)
 
Miriam Sanchez-Escamilla
No Relationships to Disclose
 
Roni Tamari
No Relationships to Disclose
 
Brian Carl Shaffer
No Relationships to Disclose
 
Craig Steven Sauter
Consulting or Advisory Role - Gilead Sciences; Juno Therapeutics; Novartis; Precision Biosciences; Sanofi; Spectrum Pharmaceuticals
Research Funding - Juno Therapeutics; Sanofi
Travel, Accommodations, Expenses - Gilead Sciences; Juno Therapeutics; Novartis; Sanofi
 
Esperanza Bouza Papadopoulos
Leadership - Biogen (I); Exelixis (I); Regulus Therapeutics (I)
Stock and Other Ownership Interests - Apellis Pharmaceuticals (I); AVEO (I); BG Medicine (I); Biogen (I); Evelo Therapeutics (I); Exelixis (I); Leap Therapeutics (I); Proteostasis Therapeutics (I); Regulus Therapeutics (I)
Consulting or Advisory Role - Codiak Biosciences (I); Evelo Therapeutics (I); Proteostasis Therapeutics (I)
Research Funding - Celgene
Travel, Accommodations, Expenses - Biogen (I); Codiak Biosciences (I); Evelo Therapeutics (I); Exelixis (I); Proteostasis Therapeutics (I); Regulus Therapeutics (I)
 
Hugo Castro-Malaspina
No Relationships to Disclose
 
Boglarka Gyurkocza
No Relationships to Disclose
 
Juliet Naomi Barker
Honoraria - Angiocrine Bioscience; Gamida Cell; Nohla Therapeutics
Consulting or Advisory Role - Angiocrine Bioscience
Research Funding - Angiocrine Bioscience; Gamida Cell
Other Relationship - Magenta Therapeutics
 
Molly A Maloy
No Relationships to Disclose
 
Beatriz Korc-Grodzicki
No Relationships to Disclose
 
Sergio Giralt
Honoraria - Amgen; Celgene; Jazz Pharmaceuticals; Sanofi; Takeda
Consulting or Advisory Role - Actinuum; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Jazz Pharmaceuticals; Johnson & Johnson; Pfizer; Sanofi; Takeda
Research Funding - Actinuum; Amgen; Celgene (Inst); Celgene (Inst); Johnson & Johnson; Miltenyi Biotec (Inst); Sanofi; Takeda
Travel, Accommodations, Expenses - Amgen; Celgene; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Sanofi